SELENBP1 expression is closely related to the prognosis of NPC patients, but also may be a more effective predictor for tumor recurrence or metastasis, and such a conclusion guides our follow-up treatment. The gene discussed is SELENBP1; the disease is nasopharyngeal carcinoma.